Menthol pain relief gel recalled over manufacturing practice deviations
CA Botana International is recalling 4,890 bottles of Dr. Bump Natural Pain Relief Gel with Menthol 5% for CGMP deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites CGMP deviations without describing an identified defect or reported harm.
Plain-English summary
Dr. Bump Natural Pain Relief Gel, Menthol 5%, in 4 fl oz (118 mL) bottles, NDC 35192-052-18, UPC 8 18204 02513 8, distributed by 1Beauty US of Palm Desert, California and manufactured by CA Botana, is being recalled for CGMP deviations.
The recall covers 4,890 bottles from lot D54947, expiring 30 April 2028. The product was distributed in California, Colorado, Florida, Puerto Rico and Washington. The FDA has classified the recall as Class II.
The enforcement record cites the manufacturing practice deviations without describing a specific defect or health consequence, and reports no injuries.
Anyone holding a bottle from lot D54947 should follow the firm's instructions.
The recalled product
- Product
- Dr. Bump Natural Pain Relief Gel, Menthol 5%, NET WT 4 FL OZ/118 ML per bottle, Distr. by 1Beauty US LLC, Palm Desert, CA 92211. NDC: 35192-052-18, UPC 8 18204 02513 8
- Manufacturer
- CA BOTANA International, Inc.
- Category
- Drug — Topical analgesic
- Hazard
- Affected units
- 4,890
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot D54947
- exp 4/30/2028
Distribution
Part of a larger recall action
This product is one of 14 recalled by CA BOTANA International, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · CA BOTANA International, Inc.
See all →- ModerateSchwab mineral sunscreen recalled over manufacturing practice deviations at Botana
FDA (Drugs) · 2025-12-03
- ModerateMineral sunscreen recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-03
- ModerateTea tree balm recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-03
- ModerateTinted mineral sunscreen recalled over manufacturing practice deviations
FDA (Drugs) · 2025-12-03
- ModerateMineral sunscreen recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-03
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19